Showing results (361-370 of 592) with videos related to
Sort By:
Pageof 60
Digestion|January 1, 1987
Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosageP Bauerfeind, T Cilluffo, C Emde, et al.Advances in Enzyme Regulation|January 1, 1985
Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridineD Keppler, J Fauler, T Gasser, et al.The Journal of Pathology|March 4, 2000
Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinomaP Schraml, D Müller, R Bednar, et al.Journal of Neurochemistry|October 3, 2002
Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neuronesM Bauer, S Suppmann, M Meyer, et al.Pediatric Research|July 1, 1990
Pubertal growth in chronic renal failureF Schaefer, C Seidel, A Binding, et al.Archives of Neurology|February 19, 2000
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosisJ Schwarz, R Linke, M Kerner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismJ Schwarz, K Tatsch, T Gasser, et al.Experimental Neurology|March 31, 2007
Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the ratS Breit, R Bouali-Benazzouz, R C Popa, et al.Neurology|December 13, 2006
Comprehensive association analysis of the NOS2A gene with Parkinson diseaseC Schulte, M Sharma, J C Mueller, et al.Annals of Human Biology|September 1, 1984
Velocity and acceleration of height growth using kernel estimationT Gasser, W Köhler, H G Müller, et al.Pageof 60